News isn't any different to what Emtin B provided by itself!
We just have had to endure incompetence from the board and waste extra resources to figure out you need Big Pharma to let you sell your product.
They would have known from early on, what was needed and the best way forward on how to go to market on the proposed peptide. Surely a consultant could have been used to figure the best way forward, and not have all this incompetence along the way!
The board needs to go IMHO.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.494M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 54000 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 179255 | 2 |
View Market Depth
| Last trade - 16.12pm 13/09/2024 (20 minute delay) ? |
| NSB (ASX) Chart |
Day chart unavailable